Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy.

Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. Abstract Text:

    michael n neelyMichael N Neely,lorie benningLorie Benning,jiaao xuJiaao Xu,howard d stricklerHoward D Strickler,ruth m greenblattRuth M Greenblatt,howard minkoffHoward Minkoff,mary youngMary Young,james bremerJames Bremer,alexandra m levineAlexandra M Levine,andrea kovacsAndrea Kovacs,

    BACKGROUND: Among women with low or undetectable quantities of HIV-1 RNA in plasma, factors associated with genital HIV-1 RNA shedding, including choice of treatment regimen, are poorly characterized. METHODS: We measured HIV-1 RNA in cervical swab specimens obtained from participants in the Women's Interagency HIV Study who had concurrent plasma viral RNA levels <500 copies/mL, and we assessed factors associated with genital HIV shedding. The study was powered to determine the relative effects of antiretroviral protease inhibitors (PIs) versus nonnucleoside reverse transcriptase inhibitors (NNRTIs) on viral RNA shedding. RESULTS: Overall, 44 (15%) of 290 women had detectable HIV-1 RNA in cervical specimens. In the final multivariate model, shedding was independently associated with NNRTI (vs. PI) use (odds ratio [OR], 95% confidence interval [CI]: 2.24, 1.13 to 4.45) and illicit drug use (OR, 95% CI: 2.41, 0.96 to 5.69). CONCLUSIONS: This is the largest study to define risks for genital HIV-1 RNA shedding in women with low/undetectable plasma virus. Shedding in this population was common, and NNRTI-based highly active antiretroviral therapy (HAART) (vs. PI-based HAART) was associated with genital HIV shedding. Further study is required to determine the impact of these findings on transmission of HIV from mother to child or to sexual partners.

    Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. Publishing Authors By Initials

    mn neelyMN Neely,l benningL Benning,j xuJ Xu,hd stricklerHD Strickler,rm greenblattRM Greenblatt,h minkoffH Minkoff,m youngM Young,j bremerJ Bremer,am levineAM Levine,a kovacsA Kovacs,

    For similar biological phenomena, cell phenomena, and immunity: biological phenomena: microbiologic phenomena: viral physiology: virus shedding research abstracts see: biological phenomena, cell phenomena, and immunity: biological phenomena: microbiologic phenomena: viral physiology: virus shedding research

    PUBMED ID PMID:

    MEDLINE DATE:

    Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Journal of acquired immune deficiency syndromes (1

    VOLUME: 44

    Page Numbers: 38-42

    Journal Abbreviation: J. Acquir. Immune Defic. Syndr

    ISSN: 1525-4135

    DAY: 1

    MONTH: Jan

    YEAR: 2007

    Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 100892005

    Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. Keywords Mesh Terms:

    KEYWORDS: Virus Shedding

    MESH TERMS: physiopathology

    Chemical & Substance for Abstract: Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy. Information

    Substance Name: Reverse Transcriptase Inhibitors

    Registry Number: 0

    Grant and Affiliation Information for Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy.

    AFFILIATION: Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. mneely@usc.edu

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NICHD

    GRANT: U01-HD-32632

    ACRONYM: HD

    MEDLINETA: J Acquir Immune Defic Syndr

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Cervical shedding of HIV-1 RNA among women with low levels of viremia while receiving highly active antiretroviral therapy Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News